Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$258K Buy
+3,830
New +$255K 0.1% 164
2025
Q3
– Sell
-2,765
Closed -$241K – 200
2025
Q2
$241K Buy
+2,765
New +$217K 0.12% 159
2025
Q1
– Sell
-3,555
Closed -$276K – 176
2024
Q4
$276K Buy
+3,555
New +$263K 0.16% 111
2024
Q3
– Sell
-2,155
Closed -$244K – 161
2024
Q2
$244K Hold
2,155
– – 0.14% 119
2024
Q1
$299K Hold
2,155
– – 0.18% 105
2023
Q4
$267K Hold
2,155
– – 0.18% 107
2023
Q3
$201K Sell
2,155
-185
-8% -$20.9K 0.15% 124
2023
Q2
$301K Hold
2,340
– – 0.21% 79
2023
Q1
$272K Hold
2,340
– – 0.22% 87
2022
Q4
$265K Buy
+2,340
New +$257K 0.24% 86

Other funds holding DXCM

Alpha Family Trust's DXCM Position: Q2 2026 in Review

Alpha Family Trust opened a new position in DexCom (DXCM) in Q2 2026: 3,830 shares worth $258K. The stake represents 0.1% of the portfolio and ranks #164 among its holdings. This is a return to the name: Alpha Family Trust previously reported a position in DXCM as recently as Q2 2025.

Alpha Family Trust first reported a position in DXCM in Q4 2022 and has held it in 10 quarters since. The position peaked at $301K in Q2 2023. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Alpha Family Trust held 3,830 shares of DexCom worth $258K as of Q2 2026.
  • DexCom was a new Alpha Family Trust position in Q2 2026.
  • DexCom made up 0.1% of Alpha Family Trust's portfolio in Q2 2026, its #164 holding.
  • Alpha Family Trust first reported a position in DexCom in Q4 2022 and has held it in 10 quarters since.
  • Alpha Family Trust's DexCom position peaked at $301K in Q2 2023.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Alpha Family Trust's 13F filing for Q2 2026, filed 10 Aug 2026.